WATS3D Receives Medically Necessary Designation from Blue Cross Blue Shield of Kansas City
SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- WATS3D, a diagnostic platform used by physicians to detect Barretts esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a positive medically necessary designation from Blue Cross Blue Shield (BCBS) of Kansas City.
- SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- WATS3D, a diagnostic platform used by physicians to detect Barretts esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a positive medically necessary designation from Blue Cross Blue Shield (BCBS) of Kansas City.
- Members of BCBS Kansas City, Hawaii Medical Services Association (HMSA), BCBS South Carolina, and Avalon, now have access to the American Society for Gastrointestinal Endoscopy (ASGE) Guideline approved technology.
- Were excited to strengthen our medical policy status within the Blue Cross Blue Shield network with the addition of Kansas City, says CDx Diagnostics CEO Bill Huffnagle.
- Most importantly, over 600,000 individuals in the Kansas City market now have access to this potentially life-saving technology.